Rare diseases
Investigational molecules
Locations
Back to Bulgaria40 clinical trials in Pazardzhik, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
BulgariaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
BulgariaStudy on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
BulgariaPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
BulgariaA study to evaluate the effectiveness and safety of NBI-1117570 in adults with schizophrenia who require hospital treatment.
BulgariaA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
BulgariaA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
BulgariaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
BulgariaStudy on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older
BulgariaLong-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for chronic obstructive pulmonary disease (COPD) and asthma, evaluating new therapeutic approaches and medications to improve patient outcomes.
Multiple trials are exploring both established and novel therapeutic options for patients with moderate to severe respiratory conditions.
Groundbreaking research in multiple sclerosis and seizure management, with trials evaluating new therapeutic agents and treatment approaches for various neurological conditions.
Studies are investigating both progressive and relapsing forms of neurological conditions to develop more effective treatments.
Innovative research targeting heart failure and stroke prevention, including studies on new medications for atrial fibrillation and post-stroke care.
These trials aim to improve cardiovascular outcomes and reduce the risk of serious complications in high-risk patients.
Advanced research in schizophrenia and Alzheimer's disease psychosis, focusing on novel therapeutic approaches and long-term treatment solutions.
Trials are exploring new therapeutic options to address both acute symptoms and long-term disease management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
